Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
The following section summarizes insights on ARS Pharmaceuticals Inc's Tangible Book Value:
We've identified the following companies as similar to ARS Pharmaceuticals Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Tangible Book Value in the financials category include:
The book value of common equity less intangible assets.
ARS Pharmaceuticals reported tangible book value of 249.1 M for the latest quarter ending December 31, 2024 on its balance sheet.
The tables below summarizes ARS Pharmaceuticals’s Tangible Book Value and common size over the last five years:
| Fiscal Year | Tangible Book Value | Assets | % Assets |
|---|---|---|---|
| 2020-12-31 | -14.052 M | 26.407 M | −53.2% |
| 2021-12-31 | -31.269 M | 61.446 M | −50.9% |
| 2022-12-31 | 272.9 M | 281.4 M | 97.0% |
| 2023-12-31 | 230.1 M | 233.2 M | 98.7% |
| 2024-12-31 | 249.1 M | 351.2 M | 70.9% |
The tables below summarizes ARS Pharmaceuticals’s Tangible Book Value and common size over the last four quarters:
| Quarter Ending | Tangible Book Value | Assets | % Assets |
|---|---|---|---|
| 2024-03-31 | 223.9 M | 227.6 M | 98.4% |
| 2024-06-30 | 215.2 M | 222 M | 97.0% |
| 2024-09-30 | 193.5 M | 217.6 M | 88.9% |
| 2024-12-31 | 249.1 M | 351.2 M | 70.9% |